Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion

Amr Moursi, Phillip L. Winnard, Alissa V. Winnard, John M. Rubenstrunk, Mark P. Mooney

Research output: Contribution to journalArticle

Abstract

Objective: Craniosynostosis has been associated with fibroblast growth factors (FGFs) and their receptors. The purpose of this study was to quantitatively determine the effect of FGF2 on rat calvarial osteoblasts and a rat cranial suture formation model. Design: Fetal rat calvarial osteoblasts were cultured with and without FGF2. Cell attachment and proliferation was determined by alamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, post-natal day 15 rat calvariae with dura mater were placed in serum-free media with and without FGF2. A unique quantitative analysis of suture fusion was developed by obtaining measurements of suture bridging in histological serial sections at progressive stages of fusion. Results: Attachment for cells treated with FGF2 was similar to control. In contrast, proliferation was higher for cells treated with FGF2 while maintaining an osteoblastic morphology. After 5 days in organ culture, FGF2-treated posterior frontal sutures showed a dramatic increase in fusion, compared with untreated controls. This increased fusion was maintained throughout days 7 and 10 in culture. Also, fusion was enhanced on the dural side of the suture, as is normally observed in vivo, and the normal tissue architecture was maintained. Conclusions: These results indicate that FGF2 can promote rat osteoblast attachment and normal cell morphology as well as induce cell proliferation. In calvarial organ culture, FGF2 treatment produced an enhanced suture fusion. These results provide further support for a critical role for FGF2 in cranial suture development. These studies also present a new quantitative approach to evaluating the effect of suture-perturbing growth factors on cranial suture fusion.

Original languageEnglish (US)
Pages (from-to)487-496
Number of pages10
JournalCleft Palate-Craniofacial Journal
Volume39
Issue number5
DOIs
StatePublished - Sep 2002

Fingerprint

Cranial Sutures
Fibroblast Growth Factor 2
Osteoblasts
Sutures
Organ Culture Techniques
Cell Proliferation
Fibroblast Growth Factor Receptors
Dura Mater
Craniosynostoses
Tolonium Chloride
Serum-Free Culture Media
Skull
Intercellular Signaling Peptides and Proteins
Coloring Agents
Staining and Labeling

Keywords

  • Cranial suture
  • Craniosynostosis
  • FGF2
  • Osteoblast

ASJC Scopus subject areas

  • Surgery
  • Dentistry(all)

Cite this

Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. / Moursi, Amr; Winnard, Phillip L.; Winnard, Alissa V.; Rubenstrunk, John M.; Mooney, Mark P.

In: Cleft Palate-Craniofacial Journal, Vol. 39, No. 5, 09.2002, p. 487-496.

Research output: Contribution to journalArticle

Moursi, Amr ; Winnard, Phillip L. ; Winnard, Alissa V. ; Rubenstrunk, John M. ; Mooney, Mark P. / Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. In: Cleft Palate-Craniofacial Journal. 2002 ; Vol. 39, No. 5. pp. 487-496.
@article{ca0a524135764da8a2732233d61e200f,
title = "Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion",
abstract = "Objective: Craniosynostosis has been associated with fibroblast growth factors (FGFs) and their receptors. The purpose of this study was to quantitatively determine the effect of FGF2 on rat calvarial osteoblasts and a rat cranial suture formation model. Design: Fetal rat calvarial osteoblasts were cultured with and without FGF2. Cell attachment and proliferation was determined by alamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, post-natal day 15 rat calvariae with dura mater were placed in serum-free media with and without FGF2. A unique quantitative analysis of suture fusion was developed by obtaining measurements of suture bridging in histological serial sections at progressive stages of fusion. Results: Attachment for cells treated with FGF2 was similar to control. In contrast, proliferation was higher for cells treated with FGF2 while maintaining an osteoblastic morphology. After 5 days in organ culture, FGF2-treated posterior frontal sutures showed a dramatic increase in fusion, compared with untreated controls. This increased fusion was maintained throughout days 7 and 10 in culture. Also, fusion was enhanced on the dural side of the suture, as is normally observed in vivo, and the normal tissue architecture was maintained. Conclusions: These results indicate that FGF2 can promote rat osteoblast attachment and normal cell morphology as well as induce cell proliferation. In calvarial organ culture, FGF2 treatment produced an enhanced suture fusion. These results provide further support for a critical role for FGF2 in cranial suture development. These studies also present a new quantitative approach to evaluating the effect of suture-perturbing growth factors on cranial suture fusion.",
keywords = "Cranial suture, Craniosynostosis, FGF2, Osteoblast",
author = "Amr Moursi and Winnard, {Phillip L.} and Winnard, {Alissa V.} and Rubenstrunk, {John M.} and Mooney, {Mark P.}",
year = "2002",
month = "9",
doi = "10.1597/1545-1569(2002)039<0487:FGFIIC>2.0.CO;2",
language = "English (US)",
volume = "39",
pages = "487--496",
journal = "Cleft Palate-Craniofacial Journal",
issn = "1055-6656",
publisher = "American Cleft Palate Craniofacial Association",
number = "5",

}

TY - JOUR

T1 - Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion

AU - Moursi, Amr

AU - Winnard, Phillip L.

AU - Winnard, Alissa V.

AU - Rubenstrunk, John M.

AU - Mooney, Mark P.

PY - 2002/9

Y1 - 2002/9

N2 - Objective: Craniosynostosis has been associated with fibroblast growth factors (FGFs) and their receptors. The purpose of this study was to quantitatively determine the effect of FGF2 on rat calvarial osteoblasts and a rat cranial suture formation model. Design: Fetal rat calvarial osteoblasts were cultured with and without FGF2. Cell attachment and proliferation was determined by alamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, post-natal day 15 rat calvariae with dura mater were placed in serum-free media with and without FGF2. A unique quantitative analysis of suture fusion was developed by obtaining measurements of suture bridging in histological serial sections at progressive stages of fusion. Results: Attachment for cells treated with FGF2 was similar to control. In contrast, proliferation was higher for cells treated with FGF2 while maintaining an osteoblastic morphology. After 5 days in organ culture, FGF2-treated posterior frontal sutures showed a dramatic increase in fusion, compared with untreated controls. This increased fusion was maintained throughout days 7 and 10 in culture. Also, fusion was enhanced on the dural side of the suture, as is normally observed in vivo, and the normal tissue architecture was maintained. Conclusions: These results indicate that FGF2 can promote rat osteoblast attachment and normal cell morphology as well as induce cell proliferation. In calvarial organ culture, FGF2 treatment produced an enhanced suture fusion. These results provide further support for a critical role for FGF2 in cranial suture development. These studies also present a new quantitative approach to evaluating the effect of suture-perturbing growth factors on cranial suture fusion.

AB - Objective: Craniosynostosis has been associated with fibroblast growth factors (FGFs) and their receptors. The purpose of this study was to quantitatively determine the effect of FGF2 on rat calvarial osteoblasts and a rat cranial suture formation model. Design: Fetal rat calvarial osteoblasts were cultured with and without FGF2. Cell attachment and proliferation was determined by alamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, post-natal day 15 rat calvariae with dura mater were placed in serum-free media with and without FGF2. A unique quantitative analysis of suture fusion was developed by obtaining measurements of suture bridging in histological serial sections at progressive stages of fusion. Results: Attachment for cells treated with FGF2 was similar to control. In contrast, proliferation was higher for cells treated with FGF2 while maintaining an osteoblastic morphology. After 5 days in organ culture, FGF2-treated posterior frontal sutures showed a dramatic increase in fusion, compared with untreated controls. This increased fusion was maintained throughout days 7 and 10 in culture. Also, fusion was enhanced on the dural side of the suture, as is normally observed in vivo, and the normal tissue architecture was maintained. Conclusions: These results indicate that FGF2 can promote rat osteoblast attachment and normal cell morphology as well as induce cell proliferation. In calvarial organ culture, FGF2 treatment produced an enhanced suture fusion. These results provide further support for a critical role for FGF2 in cranial suture development. These studies also present a new quantitative approach to evaluating the effect of suture-perturbing growth factors on cranial suture fusion.

KW - Cranial suture

KW - Craniosynostosis

KW - FGF2

KW - Osteoblast

UR - http://www.scopus.com/inward/record.url?scp=0036708393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036708393&partnerID=8YFLogxK

U2 - 10.1597/1545-1569(2002)039<0487:FGFIIC>2.0.CO;2

DO - 10.1597/1545-1569(2002)039<0487:FGFIIC>2.0.CO;2

M3 - Article

VL - 39

SP - 487

EP - 496

JO - Cleft Palate-Craniofacial Journal

JF - Cleft Palate-Craniofacial Journal

SN - 1055-6656

IS - 5

ER -